Chapter 2 Tissue Diagnostics: Technologies and Global Markets
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview and Definitions
- Immunohistochemistry (IHC)
- In Situ Hybridization
- Polymerase Chain Reaction
- Next-Generation Sequencing
- General Culture Testing
- Market Dynamics
- Market Drivers
- Market Opportunities
- Market Restraints
- Market Challenges
- Emerging Technologies and Developments
- Market Breakdown
- Market Breakdown by Product Type
- Market Breakdown by Segment
- Histopathology Market
- Molecular Pathology Market
- Microbiology Testing Market
- Digital Pathology Market
- Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest of the World
- Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
- Introduction to ESG
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market
- Market Outlook
- Scope of Report
- Market Insights
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
- Market Analysis by Test Type
- Colonoscopy and Sigmoidoscopy Tests
- Stool DNA Tests
- Blood-Based/Biomarker Tests
- Fecal Occult Blood Tests (FOBT)
- Fecal Immunochemical Tests (FIT)
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
- Introduction
- Sustainability
- Concluding Remarks
Chapter 4 Oncology Diagnostics: Global Markets
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Strategic Initiatives
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Opportunities
- Market Restraints
- Market Challenges
- Emerging Technologies
- Global Market Insights
- Market Breakdown by Product Type
- Diagnostics Imaging
- Endoscopy Devices
- Tumor Biomarker Tests
- Biopsy Devices
- Hematoxylin and Eosin
- Immunohistochemistry
- In situ Hybridization
- Polymerase Chain Reaction
- Next-Generation Sequencing
- Others
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa (MEA)
- Sustainability in the Market for Oncology Diagnostics: An ESG Perspective
- Introduction to ESG
- ESG Performance Analysis
- Concluding Remarks
Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Market Trends
- Global Market for Liquid Biopsy by Application
- Non-invasive Prenatal Testing (NIPT)
- Cancer
- Organ Transplantation
- Global Market for Liquid Biopsy by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
- Sustainability in the Liquid Biopsy Market: ESG Perspective
- Introduction to ESG
- ESG Practices in the Liquid Biopsy Industry
- Environmental Performance
- Social Performance
- Governance Performance
- ESG Risk Ratings
- Concluding Remarks
Chapter 6 Human Microbiome-based Drugs and Diagnostics
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics
- Emerging Technologies
- Analysis by Segment
- Regional Analysis
- Conclusion
- Overview and Market Definition
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Market Analysis by Type
- Microbiome-based Drugs
- Microbiome-based Diagnostics
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Sustainability in the Human Microbiome-based Drugs and Diagnostics Industry: An ESG Perspective
- Introduction to ESG
- ESG Risk Ratings
- Concluding Remarks
Chapter 7 Molecular Diagnostics: Technologies and Global Markets
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Market Analysis by Technology
- Key Takeaways
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- Microarrays
- Others
- Market Analysis by Product and Service
- Key Takeaways
- Consumables
- Instruments
- Software and Services
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Molecular Diagnostics Market: An ESG Perspective
- Introduction to ESG
- ESG Practices in the Molecular Diagnostics Industry
- ESG Risk Ratings
- Conclusion
Chapter 8 In Vitro Diagnostics: Technologies and Global Markets
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies in the IVD Market
- Market Analysis by Technology
- Immunochemistry
- POC Testing
- Hematology
- Molecular Diagnostics
- Tissue Diagnostics
- Clinical Microbiology
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
- Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
- Importance of ESG in In Vitro Diagnostics Manufacturing Industry
- ESG Practices in the In Vitro Diagnostics Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Company Role in ESG Development
- ESG Risk Ratings
- BCC Research Viewpoint
Chapter 9 Global Markets for Allergy Diagnostics and Treatments
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Global Allergy Diagnostics and Treatment Market by Type
- Key Takeaways
- Diagnostics
- Treatments
- Global Allergy Diagnostics and Treatment Market by Drug Type
- Key Takeaways
- Prescription Drugs
- Over-the-Counter Drugs
- Global Allergy Diagnostics and Treatment Market by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa (MEA)
- South America
- Sustainability in the Allergy Diagnostics and Treatment Market:ESG Perspective
- Introduction to ESG
- Role of ESG in the Allergy Diagnostics and Treatment Market
- ESG Risk Ratings
- Conclusion
Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Market Outlook
- Scope of the Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Current Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Emerging Technologies
- Market Analysis by Cancer Type
- Key Takeaways
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Stomach Cancer
- Liver Cancer
- Esophageal Cancer
- Bladder Cancer
- All Other Cancers
- Market Analysis by Technology Type
- Key Takeaways
- Diagnostic Imaging Technologies
- Advanced Noninvasive Approaches
- Conventional Noninvasive Cancer Screening, Diagnostic Assays and Tests
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Sustainability in Global Noninvasive Cancer Diagnostics Market: An ESG Perspective
- Introduction to ESG
- Major Manufacturers: ESG Efforts
- Concluding Remarks
Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics
- Market Outlook
- Scope of Report
- Market Summary
- Overview
- Current Market Scenario
- Segmental Analysis
- Technological Advances
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Emerging Technologies
- Global Diabetes Therapeutics and Diagnostic Market by Product
- Key Takeaways
- Diabetes Therapeutics
- Diabetes Monitoring Devices and Accessories
- Insulin Delivery Devices
- Global Diabetes Therapeutics and Diagnostic Market by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
- Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
- Introduction to ESG
- ESG in Diabetes Therapeutics and Diagnostics
- ESG Performance Analysis
- Concluding Remarks
List of Tables
Table 1: Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 2: Global Incidence of All Cancers, by Region, 2022-2045
Table 3: Cancer Cases, by Country, 2022
Table 4: Incidence of Cancer, by Cancer Type, 2022
Table 5: Global Tissue Diagnostics Market, Through 2029
Table 6: Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 7: Global Tissue Diagnostics Market, by Segment Type, Through 2029
Table 8: Global Tissue Diagnostics Market, by Region, Through 2029
Table 9: ESG: Environmental Overview
Table 10: ESG: Social Overview
Table 11: ESG: Governance Overview
Table 12: Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 13: Countries with Highest Colorectal Cancer Incidence and Rates, 2022
Table 14: Successful Colorectal Cancer Screening Initiatives, 2004-2011
Table 15: Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
Table 16: Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 17: Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 18: Recent ESG Highlights from Select Testing Services Providing Companies
Table 19: ESG Rankings for a Few Service-Providing Companies, 2024
Table 20: ESG Rankings for Major Product Manufacturing Companies, 2024
Table 21: Global Market for Oncology Diagnostics, by Product Type, Through 2029
Table 22: Cancer Treatments Based on Specific Tests
Table 23: Select FDA-Approved AI-Associated/Associable-Equipped Medical Devices
Table 24: Global Oncology Diagnostics Market, by Product Type, Through 2029
Table 25: Global Oncology Diagnostics Market, by Region, Through 2029
Table 26: ESG: Environmental Overview
Table 27: ESG: Social Overview
Table 28: ESG: Governance Overview
Table 29: Global Market for Liquid Biopsy, by Region, Through 2029
Table 30: Liquid Biopsy Sample Types and Characteristics
Table 31: Global Market for Liquid Biopsy, by Application, Through 2029
Table 32: Global Market for Liquid Biopsy, by Region, Through 2029
Table 33: Key Focus Areas in ESG Metrics
Table 34: Environmental Performance Initiatives in the Liquid Biopsy Market
Table 35: Social Performance Initiatives in the Liquid Biopsy Market
Table 36: Governance Performance Initiatives in the Liquid Biopsy Market
Table 37: ESG Rankings for Leaders in the Market for Liquid Biopsy, 2024*
Table 38: Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
Table 39: Diseases Associated with Microbiome Dysbiosis
Table 40: Global Market for Human Microbiome-based Drugs and Diagnostics, by Type, Through 2030
Table 41: Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
Table 42: ESG Goals of Human Microbiome-based Drugs and Diagnostics Companies
Table 43: ESG Risk Ratings for Human Microbiome-based Drugs and Diagnostics Firms, 2025
Table 44: Global Molecular Diagnostics Market, by Region, Through 2030
Table 45: Global Molecular Diagnostics Market, by Technology, Through 2030
Table 46: Global Molecular Diagnostics Market, by Product and Service, Through 2030
Table 47: Global Molecular Diagnostics Market, by Region, Through 2030
Table 48: Environmental Performance Initiatives in the Molecular Diagnostics Market
Table 49: Social Performance Initiatives in the Molecular Diagnostics Market
Table 50: Governance Performance Initiatives in the Molecular Diagnostics Market
Table 51: ESG Risk Rankings for Molecular Diagnostics Companies, 2025
Table 52: Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 53: Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 54: Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 55: Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 56: ESG Practices: Environmental Performance
Table 57: ESG Practices: Social Performance
Table 58: ESG Practices: Governance Performance
Table 59: Creating an Attractive Workplace: Social Performance
Table 60: ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 61: Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 62: Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
Table 63: Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
Table 64: Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
Table 65: ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
Table 66: Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
Table 67: Types of Liquid Biopsy and Their Clinical Applications, 2024
Table 68: Estimated Cancer Incidence, Age (0-85+), 2022-2045
Table 69: Estimated Cancer Incidence in Males in the U.S., by Cancer Site, 2025
Table 70: Estimated Cancer Incidence in Females in the U.S., by Cancer Site, 2025
Table 71: Global Market for Noninvasive Cancer Diagnostics, by Cancer Type, Through 2030
Table 72: Global Market for Noninvasive Cancer Diagnostics, by Technology Type, Through 2030
Table 73: Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
Table 74: ESG Highlights, by Major Players, 2024
Table 75: Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
Table 76: Indonesia: Price Ranges of Diabetes Monitoring Products, by Sector, 2024
Table 77: Selected Technology Integrated Products
Table 78: Global Market for Diabetes Therapeutics and Diagnostics, by Product, Through 2030
Table 79: Global Revenues of Leading Diabetes-Focused Pharmaceutical Companies,2023 and 2024
Table 80: Major Companies: Diabetes Therapeutic Pipeline
Table 81: Insulin vs. GLP-1 Therapy
Table 82: Standard GLP-1 RAs vs. Dual/Triple Agonists
Table 83: Comparison of Different Types of Insulins
Table 84: Oral Antidiabetic Drugs Overview
Table 85: Blood Glucose Test Strips, by Manufacturer
Table 86: Blood Glucose Meters, by Manufacturer
Table 87: Continuous Glucose Monitoring Systems, by Manufacturer
Table 88: Comparison of Continuous Glucose Monitoring Systems, by Company
Table 89: Lancets and Lancet Devices, by Manufacturer
Table 90: Insulin Infusion Pumps, by Manufacturer
Table 91: Insulin Pen, by Manufacturer
Table 92: Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
Table 93: Diabetes Waste Management Recommendations
Table 94: ESG Rankings for Diabetes Therapeutics and Diagnostics Companies, 2025*
Table 95: ESG: Environmental Overview
Table 96: ESG: Social Overview
Table 97: ESG: Governance Overview
List of Figures
Figure 1: Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
Figure 2: Shares of All Cancer Cases, by Region, 2022
Figure 3: Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
Figure 4: Shares of Global Market for Tissue Diagnostics, by Region, 2023
Figure 5: ESG Pillars
Figure 6: Advantages of ESG for Companies
Figure 7: Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 8: Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
Figure 9: Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 10: Snapshot of ESG Pillars
Figure 11: Global Market Shares of Oncology Diagnostics, by Product Type, 2023
Figure 12: Number of FDA-Approved Companion Diagnostic Devices, 1997-2024
Figure 13: Share of Global Market for Oncology Diagnostics, by Product Type, 2023
Figure 14: Share of Global Market for Oncology Diagnostics, by Region, 2023
Figure 15: ESG Pillars
Figure 16: Advantages of ESG for Companies
Figure 17: Global Market Shares of Liquid Biopsy, by Application 2024
Figure 18: Estimated Number of New Cancer Cases Globally, 2022, 2045 and 2050
Figure 19: Global Market Shares of Liquid Biopsy, by Region, 2024
Figure 20: How a Strong ESG Proposition Benefits Businesses?
Figure 21: Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
Figure 22: Diseases and Conditions Associated with Dysbiosis
Figure 23: Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Type, 2024
Figure 24: Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
Figure 25: Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 26: Global Molecular Diagnostics Market Shares, by Technology, 2024
Figure 27: Global Molecular Diagnostics Market Shares, by Product and Service, 2024
Figure 28: Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 29: Key ESG Metrics of Molecular Diagnostics Companies
Figure 30: Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 31: Emerging AI Applications in In Vitro Diagnostics
Figure 32: Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 33: Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 34: SNAPSHOT: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 35: Global Market Shares of Allergy Diagnostic and Treatments, by Region, 2024
Figure 36: Global Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
Figure 37: Global Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
Figure 38: Global Market Shares of Allergy Diagnostics and Treatment, by Region, 2024
Figure 39: Pillars of ESG
Figure 40: Advantages of ESG for Companies
Figure 41: Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
Figure 42: Global Market Shares for Noninvasive Cancer Diagnostics, by Cancer Type, 2024
Figure 43: Global Market Shares for Noninvasive Cancer Diagnostics, by Technology Type, 2024
Figure 44: Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
Figure 45: Pillars of Sustainable Cancer Care
Figure 46::Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
Figure 47: DIABETES: Type
Figure 48: Estimated Number of People Aged 20 to 79 With Diabetes, Globally, 2000-2024
Figure 49: Global Market Shares for Diabetes Therapeutics and Diagnostics, by Product, 2024
Figure 50: Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
Figure 51: ESG Pillars
Figure 52: Advantages of ESG for Companies
Figure 53: Diabetes Therapeutics and Diagnostics: Key ESG Issues
